Endogenous galectin-1 exerts tonic inhibition on experimental arthritis. - Wikidata - awgldk - TriplyDB

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

http://www.wikidata.org/entity/Q37676907

about

Bone Marrow Mesenchymal Stem Cells Inhibit the Function of Dendritic Cells by Secreting Galectin-1.Galectin-1 regulates tissue exit of specific dendritic cell populations.Galectins in the Pathogenesis of Rheumatoid Arthritis.Galectin-3 Induces a Pro-degradative/inflammatory Gene Signature in Human Chondrocytes, Teaming Up with Galectin-1 in Osteoarthritis Pathogenesis.Galectin-1 Couples Glycobiology to Inflammation in Osteoarthritis through the Activation of an NF-κB-Regulated Gene Network.Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology.Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo.Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation.Anti-inflammatory effect of galectin-1 in a murine model of atopic dermatitis.Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity

P2860

Q33872923-EC3FC77B-D6E6-43F8-8B8B-D7E559C0000E Q36049988-12153272-5471-4A64-AE1E-87C1F263B30A Q37457505-6C049450-430F-447E-BCE2-230508738D71 Q37508714-E4E39052-BCE1-49D3-8D2B-C43B846889A0 Q38294225-6D9AA972-332F-490A-9363-47F4651E9593 Q42407157-E75A0EF0-2803-49BB-B44F-7CE06B55E0C0 Q47132202-C403A6A8-7F65-4428-BC9E-F08F2E661748 Q47143242-BEE53F2B-CFCD-40F8-968D-983345E840B1 Q47381420-C42605D3-F6DA-4594-A483-4DD87BC9506A Q50915550-D8D57132-379A-48B6-9261-9EABA1FB519B Q57491420-4BE7DAF6-854C-4B30-8D2F-07DFA12F500C

P2860

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

http://www.wikidata.org/entity/Q37676907

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

@en

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

@nl

type

label

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

@en

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

@nl

prefLabel

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

@en

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

@nl

P1433

Q37676907-CE9639BF-73CB-4971-9567-2B8B268F3D03

P1476

Q37676907-0BC8BA11-107E-4F20-9AB4-0D0238F37552

P2093

Q37676907-37AAA377-61F7-4EA4-A63E-CE3D0EE5A71A

Q37676907-50D16B24-A228-43BC-B456-2502B9457A84

Q37676907-545F58BE-6659-4615-85A1-AC1BE3CB2210

Q37676907-7213E41A-A165-43B1-8888-9466971103BD

Q37676907-823A4E4D-E230-4FE3-AA1A-06E2555D5E58

Q37676907-F4F813F6-A5A5-4AFB-B97E-F04E09687A5C

P2860

Q37676907-0191CF0D-C04A-4940-99B7-E0D14D633D99

Q37676907-01B2C6E6-E295-45DE-8744-73F4DCD51C93

Q37676907-06713246-464E-44E9-9E9E-03DBE0D8B7CF

Q37676907-19D105D3-9F12-4238-87C5-E66CDCE2B02F

Q37676907-32978B1F-BA61-44B8-8034-6231C6A75B4A

Q37676907-3A3B04AD-9860-4D07-A493-1E39D828BB6B

Q37676907-3AA99D71-0BB4-47A3-A90D-306C71951C44

Q37676907-3E0DA992-B570-44F9-ADB2-8AFF272AFE51

Q37676907-43381387-1B3F-47D9-A972-03201F47977A

Q37676907-5254DEAE-2405-4FAD-81F1-ACD93645D9E8

P304

Q37676907-35BCE632-5D14-4D59-A323-93BAD08FB898

P31

Q37676907-EBE547DD-EB7B-47DF-9A99-5D5A5216A48B

P356

Q37676907-535CAB7C-572D-4317-BE1E-B26948F0636B

P407

Q37676907-B9ADE716-7001-40C8-BBE5-22338BF4F00F

P433

Q37676907-11306F00-DDF9-413C-873F-8DC5A902191A

P478

Q37676907-4D73DCDD-8EAD-42FB-A39C-E23817C2C8B5

P577

Q37676907-C9091BBB-F45B-4060-9382-80F35D277275

P5875

Q37676907-B983C0EA-B77C-4B46-B347-86814CE65841

P698

Q37676907-8A70287A-14BB-4767-B8E1-F4B39D708217

P932

Q37676907-2C4CF161-B6AE-452D-9C31-9130DEB820C7

P356

JIMMUNOL.1203291

P1433

Journal of Immunology

P1476

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis.

@en

P2093

Adrian Moore

http://www.w3.org/2001/XMLSchema#string

Alexander Vugler

http://www.w3.org/2001/XMLSchema#string

Asif J Iqbal

http://www.w3.org/2001/XMLSchema#string

Beatrice R Gittens

http://www.w3.org/2001/XMLSchema#string

Dianne Cooper

http://www.w3.org/2001/XMLSchema#string

Mauro Perretti

http://www.w3.org/2001/XMLSchema#string

P2860

Galectins: regulators of acute and chronic inflammation

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Proinflammatory T helper type 17 cells are effective B-cell helpers

Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.

Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis

Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).

Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect.

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.

P304

171-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1203291

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236968978

http://www.w3.org/2001/XMLSchema#string

P698

23720814

http://www.w3.org/2001/XMLSchema#string

P932

3971374

http://www.w3.org/2001/XMLSchema#string